In vitro activities of benflumetol against 158 Senegalese isolates of Plasmodium falciparum in comparison with those of standard antimalarial drugs
- PMID: 9925550
- PMCID: PMC89095
- DOI: 10.1128/AAC.43.2.418
In vitro activities of benflumetol against 158 Senegalese isolates of Plasmodium falciparum in comparison with those of standard antimalarial drugs
Abstract
The 50% inhibitory concentration (IC50s) of benflumetol (range, 12.5 to 240 nM; mean, 55.1 nM) for 158 Senegalese isolates were evaluated. Ten isolates (6%) showed decreased susceptibility to benflumetol. Benflumetol was slightly more potent against chloroquine-resistant isolates (P < 0.025). No correlation or weak correlations in the responses to benflumetol and pyrimethamine, chloroquine, amodiaquine, artemether, quinine, and pyronaridine were observed, and these correlations are insufficient to suggest cross-resistance. Benflumetol may be an important alternative drug for the treatment of chloroquine-resistant malaria.
References
-
- Dorn A, Vippagunta S R, Matile H, Jaquet C, Vennerstrom J L, Ridley R G. An assessment of drug-haematin as a mechanism for inhibition of haematin polymerisation by quinoline antimalarials. Biochem Pharmacol. 1998;55:727–736. - PubMed
-
- Fitch C D. Antimalarial schizonticides: ferriprotoporphyrin IX interaction hypothesis. Parasitol Today. 1986;2:330–331. - PubMed
-
- Hatz C, Abdulla S, Mull R, Scellenberg D, Gathmann I, Kibatala P, Beck H P, Tanner M, Royce C. Efficacy and safety of CGP 56697 (artemether and benflumetol) compared with chloroquine to treat acute malaria in Tanzanian children aged 1–5 years. Trop Med Int Health. 1998;3:498–504. - PubMed
-
- Jelinek T, Schelbert P, Loescher T, Eichenlaub D. Quinine resistant falciparum malaria acquired in East Africa. Trop Med Parasitol. 1995;46:38–40. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
